Surface Oncology | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Surface Oncology | S-8 POS: S-8 POS
Surface Oncology | S-8 POS: S-8 POS
Surface Oncology | S-8 POS: S-8 POS
Surface Oncology | S-8 POS: S-8 POS
Surface Oncology | S-8 POS: S-8 POS
Surface Oncology | S-8 POS: S-8 POS
Surface Oncology | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Surface Oncology | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Surface Oncology | 8-K: Current report
Surface Oncology | DEFA14A: Others
Surface Oncology | DEFA14A: Others
Surface Oncology | 8-K: Current report
Surface Oncology | 8-K: Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
Surface Oncology | DEFM14A: Definitive proxy statement relating to merger or acquisition
Surface Oncology | 8-K: Current report
Surface Oncology | 8-K: Current report
Surface Oncology | 8-K: Current report
Surface Oncology | 8-K: Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023
Surface Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data
No Data